Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $5.20M | $0.81 | $32.67 | 3,952.98% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $18.14M | $0.43 | $13.00 | 2,902.31% | Strong Buy | 2 | N/A | N/A | -4,247.85% | -262.68% | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $2.27M | $1.88 | $45.00 | 2,293.62% | Strong Buy | 2 | N/A | N/A | N/A | -503.12% | |||
| IMA | IMAGENEBIO INC | $33.58M | $8.35 | $153.00 | 1,732.34% | Buy | 2 | N/A | N/A | -21.45% | -19.70% | |||
| ACXP | ACURX PHARMACEUTICALS INC | $10.46M | $6.60 | $95.50 | 1,346.97% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| ATYR | ATYR PHARMA INC | $86.60M | $0.97 | $13.63 | 1,300.31% | Buy | 4 | N/A | N/A | -38.51% | -29.72% | |||
| PSTV | PLUS THERAPEUTICS INC | $59.56M | $0.60 | $8.00 | 1,233.33% | Strong Buy | 4 | 55.12% | N/A | -100.12% | -29.35% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $189.78M | $0.63 | $8.33 | 1,224.80% | Strong Buy | 3 | 9.48% | N/A | 240.73% | 48.37% | |||
| MRSN | MERSANA THERAPEUTICS INC | $52.85M | $10.59 | $140.00 | 1,222.00% | Strong Buy | 2 | -29.73% | N/A | N/A | -29.19% | |||
| FGEN | FIBROGEN INC | $44.97M | $11.12 | $146.50 | 1,217.45% | Buy | 2 | N/A | N/A | N/A | -19.48% | |||
| NRXP | NRX PHARMACEUTICALS INC | $61.87M | $3.14 | $40.00 | 1,173.89% | Strong Buy | 3 | N/A | N/A | -282.17% | 2,077.22% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $33.19M | $2.28 | $26.67 | 1,069.61% | Buy | 3 | 273.21% | N/A | N/A | -57.00% | |||
| GRI | GRI BIO INC | $5.08M | $2.02 | $22.50 | 1,013.86% | Buy | 2 | N/A | N/A | -26.77% | -15.67% | |||
| TVRD | TVARDI THERAPEUTICS INC | $45.67M | $4.87 | $53.14 | 991.23% | Strong Buy | 7 | -87.30% | N/A | -101.00% | -76.02% | |||
| UNCY | UNICYCIVE THERAPEUTICS INC | $92.55M | $5.24 | $55.50 | 959.16% | Buy | 2 | N/A | N/A | 1,628.14% | 891.77% | |||
| CING | CINGULATE INC | $20.35M | $3.76 | $39.50 | 950.53% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $19.31M | $0.71 | $7.00 | 887.31% | Strong Buy | 2 | 154.02% | N/A | -125.24% | -18.83% | |||
| MDCX | MEDICUS PHARMA LTD | $42.58M | $2.39 | $23.50 | 883.26% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| SKYE | SKYE BIOSCIENCE INC | $49.89M | $1.61 | $15.00 | 831.68% | Buy | 3 | N/A | N/A | -163.55% | -136.95% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.77M | $1.08 | $10.00 | 825.93% | Strong Buy | 2 | N/A | N/A | -120.06% | -101.23% | |||
| INTS | INTENSITY THERAPEUTICS INC | $11.48M | $0.24 | $2.25 | 822.13% | Strong Buy | 2 | N/A | N/A | -527.46% | -259.28% | |||
| NOTE | FISCALNOTE HOLDINGS INC | $61.70M | $4.30 | $37.50 | 772.09% | Strong Buy | 2 | -9.98% | N/A | -44.33% | -14.62% | |||
| JSPR | JASPER THERAPEUTICS INC | $37.87M | $2.33 | $20.14 | 764.51% | Buy | 7 | N/A | N/A | -217.81% | -110.16% | |||
| LSTA | LISATA THERAPEUTICS INC | $24.07M | $2.80 | $23.50 | 739.29% | Strong Buy | 2 | 63.92% | N/A | -33.90% | -29.66% | |||
| IMUX | IMMUNIC INC | $80.01M | $0.84 | $7.00 | 738.32% | Strong Buy | 4 | N/A | N/A | -1,067.64% | 275.15% | |||
| PASG | PASSAGE BIO INC | $22.89M | $7.20 | $59.25 | 722.92% | Strong Buy | 4 | N/A | N/A | -2.97% | -1.43% | |||
| MBRX | MOLECULIN BIOTECH INC | $15.02M | $0.50 | $4.00 | 706.45% | Buy | 2 | N/A | N/A | N/A | -603.73% | |||
| VNRX | VOLITIONRX LTD | $47.34M | $0.44 | $3.50 | 695.45% | Strong Buy | 3 | 262.15% | N/A | -322.53% | 1,178.82% | |||
| MTVA | METAVIA INC | $23.40M | $0.97 | $7.50 | 675.59% | Strong Buy | 2 | N/A | N/A | -1,174.59% | -612.40% | |||
| PMN | PROMIS NEUROSCIENCES INC | $23.73M | $0.46 | $3.50 | 664.19% | Strong Buy | 2 | N/A | N/A | N/A | -398.95% | |||
| BMEA | BIOMEA FUSION INC | $84.50M | $1.42 | $10.50 | 639.44% | Strong Buy | 6 | N/A | N/A | -277.27% | -104.26% | |||
| MYO | MYOMO INC | $40.45M | $1.07 | $7.83 | 632.06% | Buy | 3 | 13.66% | N/A | 41.18% | 18.76% | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $12.85M | $4.92 | $34.75 | 606.30% | Strong Buy | 2 | 28.07% | N/A | -3.66% | -1.72% | |||
| CTSO | CYTOSORBENTS CORP | $51.34M | $0.82 | $5.50 | 570.73% | Buy | 2 | 21.29% | N/A | N/A | N/A | |||
| ACET | ADICET BIO INC | $74.60M | $0.90 | $6.00 | 565.19% | Strong Buy | 2 | N/A | N/A | -24.95% | -21.06% | |||
| RNXT | RENOVORX INC | $42.14M | $1.15 | $7.50 | 552.17% | Buy | 2 | 283.58% | N/A | 94.84% | 73.97% | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $272.91M | $1.23 | $8.00 | 550.41% | Strong Buy | 7 | N/A | N/A | -46.85% | -34.31% | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $12.38M | $2.16 | $14.00 | 547.55% | Buy | 2 | N/A | N/A | -23.72% | -21.19% | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $12.76M | $10.12 | $65.00 | 542.29% | Buy | 2 | N/A | N/A | -67.83% | -58.29% | |||
| TIL | INSTIL BIO INC | $134.14M | $19.87 | $125.00 | 529.09% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| ANVS | ANNOVIS BIO INC | $41.90M | $2.15 | $13.50 | 527.91% | Strong Buy | 2 | N/A | N/A | -166.98% | -142.67% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $121.81M | $0.94 | $5.88 | 523.01% | Buy | 2 | N/A | N/A | -74.22% | -66.37% | |||
| HBIO | HARVARD BIOSCIENCE INC | $17.90M | $0.40 | $2.50 | 521.89% | Buy | 2 | -1.74% | N/A | 36.09% | 7.09% | |||
| NEUP | NEUPHORIA THERAPEUTICS INC | $10.68M | $4.53 | $28.00 | 518.10% | Strong Buy | 2 | -100.00% | N/A | -59.15% | -39.32% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.